We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Abbott , GE Announce Contract Termination

By Labmedica staff writers
Posted on 17 Jul 2007
Abbott (Abbott Park, IL, USA) and General Electric (GE; Norwalk. CT, USA) have mutually agreed to terminate their contract for the sale of Abbott's core laboratory and point-of-care diagnostics businesses to GE.

The two companies worked diligently to complete the transaction but were unable to reach agreement on final terms and conditions. As a result, they agreed it was in the best interests of both companies to terminate their agreement and discussions.

Abbott is a global, broad-based healthcare company devoted to the discovery, development, manufacture, and marketing of diagnostics, pharmaceuticals, and medical products, including nutritionals and devices.

GE possesses diversified technology with a large range of products for water processing and security, medical imaging, business and consumer financing, media content, and advanced materials.


Related Links:
Abbott
General Electric

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
POC Immunoassay Analyzer
Procise DX
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240

Latest Industry News

Hologic and Inpeco Partner to Advance Molecular Laboratory Automation in Europe
17 Jul 2007  |   Industry

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection
17 Jul 2007  |   Industry

Myriad Genetics to Sell Prenatal Testing Portfolio to Labcorp
17 Jul 2007  |   Industry